Liam Ratcliffe
InvestorInvestor at Access Biotechnology · General Partner at New Leaf Venture Partners · Head of Biotechnology at Access Industries · Vice President, Human Genetics at 23andMe · Manager at Halda Therapeutics · +1 more
New York, New York, United States
Writes $100K – $5M checks · typically $1.5M
Find your path to Liam
151 people in our graph share verified history with Liam — schools, employers, funds. One of them is your warm intro.
Avron MarcusunlockedLiam: together at University of Cape Town (1993–1994)
Liam: together at 23andMe
×4Liam: together at University of Cape Town
×6Liam: together at University of Michigan - Stephen M. Ross School of Business
About
Former head of worldwide clinical R&D at Pfizer, currently leading Access Biotechnology.
Invests in
Biotech
Manager at Halda Therapeutics
Intro paths
→
In turn, Liam can intro founders to Halda Therapeutics's investors below.
Board director at Arvinas Holding Co. LLC
Intro paths
→
In turn, Liam can intro founders to Arvinas Holding Co. LLC's investors below.
Arvinas Holding Co. LLC's investors · 9
5AM VenturesBoston · $100K – $4M checksAccess BiotechnologyNew York CityCanaan PartnersStamford · $500K – $20M checks · since 2015Connecticut InnovationsNew Haven · $500K – $2M checksNational Institutes of Health (NIH)since 2016Nextech InvestZurich · $648K – $3.2M checksOrbiMedNew York · $1M – $75M checks · since 2015RA CapitalBostonSolasta VenturesBoston
Experience
- Access IndustriesHead of Biotechnologycurrent2019 — presentGreater New York City Area
- New Leaf Venture PartnersManaging Director2013 — 2019
- New Leaf Venture PartnersGeneral Partner2008 — 2019
- Pfizer IncSnr VP, Pfizer Global Research and Development1996 — 2008
Skills & more
Biopharmaceuticals13Biotechnology67
From Liam's professional profile.
Colleagues at Access Biotechnology
Network3
Adam M. KoppelScout
Managing Director at Bain Capital Life Sciences
Bruce ClevelandScout
Partner at Wildcat Venture Partners
Carl GordonScout
Managing Partner at OrbiMed
Investors connected to Liam in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Liam Ratcliffe?
- Former head of worldwide clinical R&D at Pfizer, currently leading Access Biotechnology.
- Where does Liam Ratcliffe work?
- Liam Ratcliffe is at Access Biotechnology and Manager at Halda Therapeutics and Board director at Arvinas Holding Co. LLC.
- What does Liam Ratcliffe invest in?
- Liam Ratcliffe invests in Biotech.
- What check size does Liam Ratcliffe write?
- Liam Ratcliffe typically writes checks of $100K – $5M.
- Where did Liam Ratcliffe go to school?
- Liam Ratcliffe studied at University of Michigan - Stephen M. Ross School of Business (MBA); University of Cape Town (PhD, immunology); University of Cape Town (MBChB, Medicine).
Same school
Also attended University of Michigan - Stephen M. Ross School of Business448
Alexandra FarmerPrincipal at Intel Capital, North AmericaTige SavageCo-founder at RevolutionWendy XiaoPartner at NorthzoneRob LawrenceSenior Finance Associate at GreycroftHyun KooPartner at March Capital PartnersRichard GuVice President at March Capital Partners
+ 442 more
Also attended University of Cape Town268
Roelof BothaAdvisor & former Steward at Sequoia Capital; SpaceX board memberJames DetweilerVP of Investments at Felicis VenturesAvron MarcusInvestor at Index VenturesLaurel BowdenPartner at 83NorthAlan EzekowitzInvestor at Third Rock VenturesAndy VitusPartner at Scale Venture Partners
+ 262 more
Shared employers
Also worked at New Leaf Venture Partners10
Ron HuntManaging Director at New Leaf Venture PartnersCraig SlutzkinCOO / CFO at New Leaf Venture PartnersSrini AkkarajuFounder and Managing Partner at Samsara BioCapitalMike DybbsPartner at Samsara BioCapitalDoug Fisher, MDPartner at Revelation PartnersEliot CharlesPartner at Apax Digital
+ 4 more
Also worked at Pfizer Inc229
Jigar RaythathaInvestor at Third Rock VenturesAbbie CelnikerInvestor at Third Rock VenturesErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesRichard ChesworthInvestor at Third Rock VenturesMichael TaylorOperating Partner at Mission Biocapital
+ 223 more